Skip to main content
U.S. flag

An official website of the United States government

Funding for Drug Development

Drug development, from discovery to clinic, can be extremely costly. The NIDCD annual budget does not allow support for all stages of drug development. The institute does, however, encourage and support drug development to the greatest extent possible, and this includes leveraging existing federal and private resources as well as engaging in collaborative activities.

Investigators interested in support for drug development may wish to explore the programs listed below. Each has specific guidelines and project requirements so read the announcements thoroughly and contact the listed staff with any questions. While these funding opportunities do not support comprehensive coverage through the discovery and development pipeline, they provide funding options that may advance projects to the next stage and toward further funding opportunities.

The simplified schematic below provides an example of where NIH programs might contribute during the small molecule pipeline—from discovery to development. Entry and exit points and the therapeutic specificity of any given announcement vary depending on the funding program.


Development and Beyond

Pipeline diagram for Small Molecule Development Funding Opportunities.

[View text version]

A National Institute of Neurological Disorders and Stroke (NINDS)-supported course on the complexity of drug discovery and development provides a training opportunity for those interested in this topic.

*Note: PDF files can be viewed with the free Adobe Reader.

Last Updated Date: